Kymera Therapeutics, Inc. (KYMR)
84.91
-2.26
(-2.59%)
USD |
NASDAQ |
Apr 24, 16:00
84.90
-0.01
(-0.01%)
After-Hours: 20:00
Kymera Therapeutics Market Cap : 6.932B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 161.88B |
| Revolution Medicines, Inc. | 26.81B |
| Regeneron Pharmaceuticals, Inc. | 79.46B |
| Indivior Pharmaceuticals, Inc. | 4.051B |
| Structure Therapeutics, Inc. | 3.223B |
Market Cap Related Metrics
| PS Ratio | 182.88 |
| PEG Ratio | -0.9614 |
| Price to Book Value | 4.388 |
| Price | 84.91 |
| Earnings Yield | -4.33% |
| PEGY Ratio | -0.9614 |